Page 195 Acute Pain Management
P. 195




Rigler
ML,
Drasner
K,
Krejcie
TC
et
al
(1991)
Cauda
equina
syndrome
after
continuous
spinal
anesthesia.

Anesth
Analg
72(3):
275–81.

Roelants
F
(2006)
The
use
of
neuraxial
adjuvant
drugs
(neostigmine,
clonidine)
in
obstetrics.
Current

Opinion
in
Anaesthesiology
19(3):
233–7.

Roelofs
P,
Deyo
RA,
Koes
BW
et
al
(2008)
Non‐steroidal
anti‐inflammatory
drugs
for
low
back
pain.

Cochrane
Database
of
Systematic
Reviews(1):
CD000396.

Rosenblatt
MA,
Abel
M,
Fischer
GW
et
al
(2006)
Successful
use
of
a
20%
lipid
emulsion
to
resuscitate
a

patient
after
a
presumed
bupivacaine‐related
cardiac
arrest.
Anesthesiology
105(1):
217–8.

Ross
VH,
Pan
PH,
Owen
MD
et
al
(2009)
Neostigmine
decreases
bupivacaine
use
by
patient‐controlled

epidural
analgesia
during
labor:
a
randomized
controlled
study.
Anesth
Analg
109(2):
524–31.

Rosseland
LA,
Stubhaug
A,
Sandberg
L
et
al
(2003)
Intra‐articular
(IA)
catheter
administration
of

postoperative
analgesics.
A
new
trial
design
allows
evaluation
of
baseline
pain,
demonstrates
large

variation
in
need
of
analgesics,
and
finds
no
analgesic
effect
of
IA
ketamine
compared
with
IA
saline.
Pain

104(1‐2):
25–34.

Rosseland
LA
(2005)
No
evidence
for
analgesic
effect
of
intra‐articular
morphine
after
knee
arthroscopy:

a
qualitative
systematic
review.
Reg
Anesth
Pain
Med
30(1):
83–98.

Royse
CE,
Royse
AG
&
Deelen
DA
(2005)
An
audit
of
morphine
versus
fentanyl
as
an
adjunct
to

ropivacaine
0.2%
for
high
thoracic
epidural
analgesia.
Anaesth
Intensive
Care
33(5):
639–44.

Sakaguchi
Y,
Sakura
S,
Shinzawa
M
et
al
(2000)
Does
adrenaline
improve
epidural
bupivacaine
and

fentanyl
analgesia
after
abdominal
surgery?
Anaesth
Intensive
Care
28(5):
522–6.

Saryazdi
H,
Kashefi
P,
Heydari
M
et
al
(2006)
Analgesic
effects
of
intra‐articular
fentanyl,
pethidine
and

dexamethasone
after
knee
arthroscopic
surgery.
JRMS
11(3):
156–59.

Schafer
M
(1999)
Peripheral
opioid
analgesia:
from
experimental
to
clinical
studies.
Curr
Opin

Anaesthesiol
12(5):
603–7.

Schell
RM,
Brauer
FS,
Cole
DJ
et
al
(1991)
Persistent
sacral
nerve
root
deficits
after
continuous
spinal
 CHAPTER
5

anaesthesia.
Can
J
Anaesth
38(7):
908–11.

Schug
SA,
Scott
DA,
Payne
J
et
al
(1996)
Postoperative
analgesia
by
continuous
extradural
infusion
of

ropivacaine
after
upper
abdominal
surgery.
Br
J
Anaesth
76(4):
487–91.

Schug
SA
(2001)
Correction
factor
for
comparisons
between
levobupivacaine
and
racemic
bupivacaine.

Reg
Anesth
Pain
Med
26(1):
91.

Scott
DA,
Chamley
DM,
Mooney
PH
et
al
(1995)
Epidural
ropivacaine
infusion
for
postoperative
analgesia

after
major
lower
abdominal
surgery–a
dose
finding
study.
Anesth
Analg
81(5):
982–6.

Scott
DA,
Emanuelsson
BM,
Mooney
PH
et
al
(1997)
Pharmacokinetics
and
efficacy
of
long‐term
epidural

ropivacaine
infusion
for
postoperative
analgesia.
Anesth
Analg
85(6):
1322–30.

Scott
DA,
Blake
D,
Buckland
M
et
al
(1999)
A
comparison
of
epidural
ropivacaine
infusion
alone
and
in

combination
with
1,
2,
and
4
microg/mL
fentanyl
for
seventy‐two
hours
of
postoperative
analgesia
after

major
abdominal
surgery.
Anesth
Analg
88(4):
857–64.

Scott
DB,
Lee
A,
Fagan
D
et
al
(1989)
Acute
toxicity
of
ropivacaine
compared
with
that
of
bupivacaine.

Anesth
Analg
69(5):
563–9.

Senard
M,
Joris
JL,
Ledoux
D
et
al
(2002)
A
comparison
of
0.1%
and
0.2%
ropivacaine
and
bupivacaine

combined
with
morphine
for
postoperative
patient‐controlled
epidural
analgesia
after
major
abdominal

surgery.
Anesth
Analg
95(2):
444–9.

Shakespeare
DT,
Boggild
M
&
Young
C
(2003)
Anti‐spasticity
agents
for
multiple
sclerosis.
Cochrane

Database
Syst
Rev(4):
CD001332.

Simpson
DM,
Blitzer
A,
Brashear
A
et
al
(2008)
Assessment:
Botulinum
neurotoxin
for
the
treatment
of

movement
disorders
(an
evidence‐based
review):
report
of
the
Therapeutics
and
Technology
Assessment

Subcommittee
of
the
American
Academy
of
Neurology.
Neurology
70(19):
1699–706.

Sitsen
E,
van
Poorten
F,
van
Alphen
W
et
al
(2007)
Postoperative
epidural
analgesia
after
total
knee

arthroplasty
with
sufentanil
1
microg/ml
combined
with
ropivacaine
0.2%,
ropivacaine
0.125%,
or

levobupivacaine
0.125%:
a
randomized,
double‐blind
comparison.
Reg
Anesth
Pain
Med
32(6):
475–80.




 Acute
pain
management:
scientific
evidence
 147

   190   191   192   193   194   195   196   197   198   199   200